Abatacept for the Treatment of Giant Cell Arteritis

NCT04474847 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Giant Cell Arteritis

Interventions

DRUG: Abatacept
DRUG: Placebo

Sponsor

University of Pennsylvania